Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-07-09

Clinical Trial Update: Efficacy Study on Symptomatic Control of Patient With Knee Osteoarthritis Between 0.0125% of Capsaicin to Placebo [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the symptomatic relief of capsaicin 0.0125% versus placebo in knee osteoarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capsaicin (capsaicin)

Snippet

Sponsor: Khon Kaen University | Conditions: Osteoarthritis, Knee Joint, Capsicum | Phase 3 | Status: COMPLETED